Dual role of interleukin-17 in pannus growth and osteoclastogenesis in rheumatoid arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dual role of interleukin-17 in pannus growth and osteoclastogenesis in rheumatoid arthritis ; volume:13 ; number:1 ; day:4 ; month:2 ; year:2011 ; pages:1-11 ; date:2.2011
Arthritis Research & Therapy ; 13, Heft 1 (4.2.2011), 1-11, 2.2011
- Urheber
-
Itō, Hiroshi
- Beteiligte Personen und Organisationen
-
Yamada, Hidehiro
Shibata, Toshiko N.
Mitomi, Hirofumi
Nomoto, So
Ozaki, Shoichi
SpringerLink (Online service)
- DOI
-
10.1186/ar3238
- URN
-
urn:nbn:de:1111-2016050317839
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Itō, Hiroshi
- Yamada, Hidehiro
- Shibata, Toshiko N.
- Mitomi, Hirofumi
- Nomoto, So
- Ozaki, Shoichi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis
Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis
Regulation of osteoclastogenesis by mast cell in rheumatoid arthritis
DJ-1 controls T cell differentiation and osteoclastogenesis in rheumatoid arthritis
Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway
Interleukin-6 receptor in the recent-onset rheumatoid arthritis
Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage
Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis
Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis
Propionibacterium freudenreichii MJ2-derived extracellular vesicles inhibit RANKL-induced osteoclastogenesis and improve collagen-induced rheumatoid arthritis
Genetic association between interleukin-17 and susceptibility to rheumatoid arthritis
Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis
Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis
Regulation of osteoclastogenesis by mast cell in rheumatoid arthritis
DJ-1 controls T cell differentiation and osteoclastogenesis in rheumatoid arthritis
Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway
Interleukin-6 receptor in the recent-onset rheumatoid arthritis
Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage
Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis
Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis
Propionibacterium freudenreichii MJ2-derived extracellular vesicles inhibit RANKL-induced osteoclastogenesis and improve collagen-induced rheumatoid arthritis
Genetic association between interleukin-17 and susceptibility to rheumatoid arthritis
Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis
Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis
Regulation of osteoclastogenesis by mast cell in rheumatoid arthritis
DJ-1 controls T cell differentiation and osteoclastogenesis in rheumatoid arthritis
Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway
Interleukin-6 receptor in the recent-onset rheumatoid arthritis
Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage
Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis
Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis
Propionibacterium freudenreichii MJ2-derived extracellular vesicles inhibit RANKL-induced osteoclastogenesis and improve collagen-induced rheumatoid arthritis